KBL MERGER CORP. IV Business Finance Contracts & Agreements
79 Contracts & Agreements
- Escrow Agreements (1 contract)
- Investment Agreements (3)
- Note Agreements (10)
- Purchase Agreements (12)
- Registration Rights Agreements (7)
- Stock Agreements (5)
- Subscription Agreements (6)
- Underwriting Agreements (1)
- Warrant Agreements (34)
- Form of Securities Purchase Agreement (Filed With SEC on December 30, 2024)
- Form of Common Stock Purchase Warrant (December 2024 Offering) (Filed With SEC on December 30, 2024)
- Form of Warrant Inducement Agreement, by and between the Company and Holder (Filed With SEC on October 16, 2024)
- Form of Warrant to Purchase Shares of Common Stock (Filed With SEC on October 16, 2024)
- Common Stock Purchase Warrant to purchase 3,000,000 shares of common stock dated September 30, 2024, granted by 180 Life Sciences Corp. to Elray Resources, Inc (Filed With SEC on October 3, 2024)
- Asset Purchase Agreement dated September 29, 2024, by and among Elray Resources, Inc., as seller and 180 Life Sciences Corp., as purchaser (Filed With SEC on October 3, 2024)
- Amendment No.1 to the Securities Purchase Agreement, dated November 28, 2023, by and between 180 Life Sciences Corp. and the Purchaser (Filed With SEC on November 29, 2023)
- Warrant Amendment Agreement, dated November 28, 2023, by and between the Company and the Purchaser (Filed With SEC on November 29, 2023)
- Form of Warrant Agent Agreement for Pre-Funded Warrants and Common Warrants (Filed With SEC on November 29, 2023)
- Securities Purchase Agreement dated August 9, 2023, by and between 180 Life Sciences Corp. and the Institutional Investor (Filed With SEC on August 15, 2023)
- Warrant Amendment Agreement, dated August 9, 2023, by and between the Company and Armistice Capital Master Fund Ltd (Filed With SEC on August 15, 2023)
- Warrant Agent Agreement for Pre-Funded Warrants and Common Warrants, dated August 14, 2023, by and between 180 Life Sciences Corp. and Continental Stock Transfer & Trust Company (Filed With SEC on August 15, 2023)
- Form of Warrant Agent Agreement for Pre-Funded Warrants and Common Warrants (Filed With SEC on July 25, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on June 16, 2023)
- Form of Common Warrant (Filed With SEC on June 16, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on June 16, 2023)
- Amendment No. 1 to Common Stock Purchase Warrant between 180 Life Sciences Corp. and the warrant holder, dated April 5, 2023 (Filed With SEC on May 15, 2023)
- Warrant Agent Agreement for the July 2022 Common Warrants, dated July 29, 2022, by and between 180 Life Sciences Corp. and Continental Stock Transfer & Trust Company (Filed With SEC on May 5, 2023)
- Warrant Agent Agreement for Common Warrants, dated April 10, 2023 by and between 180 Life Sciences Corp. and Continental Stock Transfer & Trust Company (Filed With SEC on April 10, 2023)
- Warrant Agent Agreement for Pre-Funded Warrants, dated April 10, 2023 by and between 180 Life Sciences Corp. and Continental Stock Transfer & Trust Company (Filed With SEC on April 10, 2023)
- Securities Purchase Agreement, dated April 5, 2023, by and between 180 Life Sciences Corp. and the Purchaser (Filed With SEC on April 10, 2023)
- Form of Common Warrant (Filed With SEC on April 10, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on April 10, 2023)
- Amendment to the Warrant Agent Agreement, dated January 13, 2023, by and between 180 Life Sciences Corp. and the Warrant Agent (Filed With SEC on January 18, 2023)
- Warrant Amendment, dated January 12, 2023, by and between 180 Life Sciences Corp. and the Purchaser (Filed With SEC on January 12, 2023)
- Warrant Agent Agreement for the Common Warrants, dated December 22, 2022, by and between 180 Life Sciences Corp. and Continental Stock Transfer & Trust Company (Filed With SEC on December 22, 2022)
- Warrant Agent Agreement for the Pre-Funded Warrants, dated December 22, 2022, by and between 180 Life Sciences Corp. and Continental Stock Transfer & Trust Company (Filed With SEC on December 22, 2022)
- Securities Purchase Agreement, dated December 20, 2022, by and between 180 Life Sciences Corp. and the Purchaser (Filed With SEC on December 22, 2022)
- Form of Common Warrant (Filed With SEC on December 22, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on December 22, 2022)
- Securities Purchase Agreement dated July 17, 2022, by and between 180 Life Sciences Corp. and the Purchaser (Filed With SEC on July 19, 2022)
- Form of Common Warrant (Filed With SEC on July 19, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on July 19, 2022)
- Registration Rights Agreement dated as of August 23, 2021 by and between 180 Life Sciences Corp. and the purchasers signatory thereto (Filed With SEC on August 24, 2021)
- Securities Purchase Agreement dated as of August 19, 2021 by and between 180 Life Sciences Corp. and the purchasers identified on the signature pages thereto (Filed With SEC on August 24, 2021)
- Form of Purchaser Warrant (August 2021 Offering) (Filed With SEC on August 24, 2021)
- Form of Stock Option Agreement (Independent Directors August 2021 Grants) (Filed With SEC on August 16, 2021)
- Common Stock Purchase Warrant dated July 31, 2021, to purchase 25,000 shares of common stock of 180 Life Sciences Corp., granted to Alpha Capital Anstalt (Filed With SEC on August 2, 2021)
- Dr. Lawrence Steinman Confirmation of Rescission of Note Amendments effective February 25, 2021 (Filed With SEC on July 19, 2021)
- Sir Marc Feldmann Confirmation of Rescission of Note Amendments effective February 25, 2021 (Filed With SEC on July 19, 2021)
